Leon J A, Britt J M, Hopp R H, Mills R P, Milam A H
Department of Ophthalmology, University of Washington School of Medicine, Seattle 98195.
Invest Ophthalmol Vis Sci. 1990 Sep;31(9):1709-16.
5-Fluorouracil (5-FU) and its active metabolite 5-fluorouridine (FUR) are currently being evaluated for the treatment of proliferative vitreoretinopathy and the control of scarring after glaucoma filtering procedures. To test for retinal toxicity, the authors examined the effect of intravitreal injections of 5-FU and FUR on protein synthesis in rabbit retinal photoreceptors and ganglion cells. In addition, the toxic effect of subconjunctival 5-FU injections, after a trephine filtering procedure, on ganglion cell protein synthesis was examined. Albino rabbit eyes were given either unilateral intravitreal injections of 1 mg of 5-FU, 2.5 mg of 5-FU, or 0.1 mg of FUR, or subconjunctival injections of 3 mg of 5-FU twice daily after a trephine procedure. Quantitative autoradiography was used to study ganglion cells and photoreceptor outer segment renewal, and scintillation counting was used to quantify newly synthesized protein transported axonally from ganglion cell bodies to the superior colliculus (SC). Marked reduction of labeled protein reaching the SC was noted after either intravitreal 0.1 mg of FUR (41% inhibition after a single injection and 53% after two injections) or 2.5 mg of 5-FU (41% after one injection and 26% after two injections). This reduction was still present after 8 days in eyes receiving 0.1 mg of FUR (32%) and 2.5 mg of 5-FU (22%). Quantitative autoradiography of retinal photoreceptors and ganglion cells corroborated these data, demonstrating inhibition of outer segment renewal after one or two injections of either 0.1 mg of FUR or 2.5 mg of 5-FU. This inhibitory effect was statistically significant using the paired t-test for both drugs. No mean inhibition was observed after intravitreal 1 mg of 5-FU injections or after subconjunctival injections of 5-FU.
5-氟尿嘧啶(5-FU)及其活性代谢产物5-氟尿苷(FUR)目前正在用于增殖性玻璃体视网膜病变的治疗以及青光眼滤过术后瘢痕形成的控制的评估。为检测视网膜毒性,作者研究了玻璃体腔内注射5-FU和FUR对兔视网膜光感受器和神经节细胞蛋白质合成的影响。此外,还研究了在环钻滤过术后结膜下注射5-FU对神经节细胞蛋白质合成的毒性作用。给白化兔眼单侧玻璃体腔内注射1mg 5-FU、2.5mg 5-FU或0.1mg FUR,或在环钻术后每日两次结膜下注射3mg 5-FU。采用定量放射自显影术研究神经节细胞和光感受器外段更新,采用闪烁计数法对从神经节细胞体向中脑上丘(SC)轴突运输的新合成蛋白质进行定量。玻璃体腔内注射0.1mg FUR(单次注射后抑制41%,两次注射后抑制53%)或2.5mg 5-FU(一次注射后抑制41%,两次注射后抑制26%)后,到达SC的标记蛋白显著减少。在接受0.1mg FUR(32%)和2.5mg 5-FU(22%)的眼中,8天后这种减少仍然存在。视网膜光感受器和神经节细胞的定量放射自显影证实了这些数据,表明单次或两次注射0.1mg FUR或2.5mg 5-FU后外段更新受到抑制。使用配对t检验,两种药物的这种抑制作用均具有统计学意义。玻璃体腔内注射1mg 5-FU或结膜下注射5-FU后未观察到平均抑制作用。